Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other neoplasm 1

Conditions

Lung Neoplasms 2Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Multiple Myeloma 1Leukemia, Plasma Cell 1Leukemia 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1Asthma 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Biopsy 6fludarabine phosphate 5Immunohistochemistry 5Epoetin Alfa 5Cyclophosphamide 5Tacrolimus 4Methotrexate 4Gene Expression Profiling 4Celecoxib 4Mycophenolic Acid 3Microarray Analysis 3Imiquimod 3Etoposide 3Darbepoetin alfa 3Cyclosporine 3Colposcopy 3Busulfan 3Antilymphocyte Serum 3Aminolevulinic Acid 3Tomography, Optical Coherence 2Sirolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Melphalan 2Mass Spectrometry 2Immunoenzyme Techniques 2Filgrastim 2Fatty Acids, Omega-3 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precancerous Conditions × Budesonide × Clear all
NCT00569712 2012-03-09

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol

British Columbia Cancer Agency

Phase 1 Completed
30 enrolled
Other neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡